Welcome to our dedicated page for Now SEC filings (Ticker: DNOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind DNOW’s fluctuating inventory levels or how its DigitalNOW platform reshapes supply-chain margins? Most investors start with the DNOW annual report 10-K simplified but quickly discover hundreds of pages packed with technical tables. This page gathers every disclosure in one place and pairs it with AI-powered summaries, so DNOW SEC filings explained simply becomes reality, not wishful thinking.
Use our tools to jump straight to what matters: the DNOW quarterly earnings report 10-Q filing for working-capital swings, DNOW 8-K material events explained for sudden distributor acquisitions, and the DNOW proxy statement executive compensation to see how bonuses track free-cash-flow targets. Want to monitor leadership’s confidence? Our alerts surface DNOW Form 4 insider transactions real-time, letting you track DNOW executive stock transactions Form 4 before the market digests them. Each document appears moments after EDGAR posts, and our AI highlights segment revenue shifts, backlog changes, and covenant updates—all in plain language.
Whether you’re comparing regional sales trends, reviewing credit-facility covenants, or scanning for buyback authorizations, this page delivers the complete set of filings with context. Skip the manual download loop; let our AI handle the heavy lifting while you focus on decisions. From DNOW insider trading Form 4 transactions to a full DNOW earnings report filing analysis, every data point is here—ready for deeper insight and faster action, helping you in understanding DNOW SEC documents with AI.
DNOW (NYSE:DNOW) filed an 8-K disclosing a definitive Agreement and Plan of Merger with MRC Global. Each MRC share will be exchanged for 0.9489 DNOW shares in an all-stock transaction executed through a two-step merger that will make MRC a wholly-owned subsidiary. Closing hinges on both companies’ shareholder approvals, HSR expiration, other competition clearances, NYSE listing of new shares and an effective Form S-4.
Either party may terminate for a superior offer, triggering a $45.5 million break-up fee and up to $8.5 million in expense reimbursement. The drop-dead date is 26 Jun 2026, extendable twice to 26 Dec 2026 if regulatory approvals are outstanding. DNOW secured a $250 million incremental commitment on its ABL, raising potential capacity to $750 million to support integration liquidity. The post-close board will have ten directors, including two from MRC. A joint press release and investor presentation are furnished as exhibits.